Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.
The NCCR*Explorer allows for direct comparison of one characteristic at a time (such as Race/Ethnicity, Sex, Age, or Cancer Type) for selected groups. For example, you can compare Trends over Time in Incidence of Leukemias by Race/Ethnicity for Females Ages <20.
The following steps provide an overview on how to use the NCCR*Explorer application.
An overview of the NCCR*Explorer interface.
The controls available under More Options are dependent on the statistic. All of the possible controls that can appear in More Options:
Incidence is the number of new cases of the specific cancer site/type per 1,000,000 people in the U.S. Number of new cases per number of people in a population are also referred to as incidence rates.
Recent trends present the observed (points) and modeled (lines) annual age-adjusted rates and corresponding annual percent change (APC) trend for each joinpoint segment in the table. Modeled are estimated using the joinpoint software. Recent trends are available from 2001 through the current year of available data.
Recent rates present the age-adjusted rate for the aggregated five most recent years of the available data, in a bar chart format.
Rates by age refer to a rate for a single age for the most recent 5-year time period. NCCR provides data for individual ages up to age 39. Rates by age are also referred to as age-specific rates.
Relative survival is an estimate of the percentage of patients who would be expected to survive the effects of their cancer. It excludes the risk of dying from other causes. Relative Survival statistics compare the survival of patients diagnosed with cancer with the survival of people in the general population who are the same age, race, and sex and who have not been diagnosed with cancer.
5-year relative survival rates show the estimated percentage of patients who would be expected to survive the effects of their cancer five years or more after cancer diagnosis. It excludes the risk of dying from other. Patients diagnosed over a seven year period are included to allow enough follow-up time for an accurate measure of 5-year survival.
Cancer Prevalence is the number or percent of people alive on a certain date who have been diagnosed with cancer. In Prevalence we show complete prevalence (people alive ever diagnosed with cancer) .
Complete prevalence represents the proportion of people alive on a certain day who previously had a diagnosis of the disease, regardless of how long ago the diagnosis was, or whether the patient is still under treatment or is considered cured. Complete prevalence is presented as U.S. counts or percent for all races combined by age and sex.